2 Attractive Large Caps on Sale After Q2 Earnings

unlock icon  Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

→ The Crypto 9-5 Escape Plan (From Crypto 101 Media) (Ad)

Should you invest $1,000 in Interpublic Group of Companies right now?

Before you consider Interpublic Group of Companies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Interpublic Group of Companies wasn't on the list.

While Interpublic Group of Companies currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Interpublic Group of Companies (IPG)
4.7206 of 5 stars
$31.20+0.7%4.23%11.10Hold$35.13
Equifax (EFX)
4.8971 of 5 stars
$239.22+2.1%0.65%53.28Moderate Buy$270.19
Bristol-Myers Squibb (BMY)
4.9885 of 5 stars
$44.75+2.5%5.36%-14.44Hold$60.00
Pfizer (PFE)
4.9893 of 5 stars
$28.20-0.3%5.96%-469.84Hold$36.00
Berkshire Hathaway (BRK.B)
0.652 of 5 stars
$408.82+0.6%N/A9.24Hold$414.00
Acxiom (ACXM)
0 of 5 stars
$48.48flatN/AN/AN/A
Compare These Stocks  Add These Stocks to My Watchlist 


Featured Articles and Offers

Biotech Boom: Stocks Skyrocketing & What's Next

Biotech Boom: Stocks Skyrocketing & What's Next

Dive into biotech's latest trends with Dylan Jovine: weight loss breakthroughs, smart chemo innovations, and expert stock evaluation tips.

Search Headlines: